Gilead Sciences, Inc. (GILD)
168.99
-1.27
(-0.75%)
USD |
NASDAQ |
Nov 18, 16:00
170.50
+1.51
(+0.89%)
After-Hours: 19:45
Gilead Sciences Total Return Level : 249.53 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 249.53 |
| November 16, 2026 | 245.60 |
| November 13, 2026 | 246.34 |
| November 12, 2026 | 246.15 |
| November 11, 2026 | 248.76 |
| November 10, 2026 | 250.43 |
| November 09, 2026 | 248.16 |
| November 06, 2026 | 244.59 |
| November 05, 2026 | 245.59 |
| November 04, 2026 | 255.72 |
| November 03, 2026 | 245.44 |
| November 02, 2026 | 249.64 |
| October 30, 2026 | 250.15 |
| October 29, 2026 | 242.72 |
| October 28, 2026 | 233.32 |
| October 27, 2026 | 233.15 |
| October 26, 2026 | 232.58 |
| October 23, 2026 | 228.69 |
| October 22, 2026 | 230.38 |
| October 21, 2026 | 225.07 |
| October 20, 2026 | 229.38 |
| October 19, 2026 | 224.34 |
| October 16, 2026 | 228.91 |
| October 15, 2026 | 230.64 |
| October 14, 2026 | 225.03 |
| Date | Value |
|---|---|
| October 13, 2026 | 216.79 |
| October 12, 2026 | 220.47 |
| October 09, 2026 | 221.55 |
| October 08, 2026 | 215.59 |
| October 07, 2026 | 215.22 |
| October 06, 2026 | 211.38 |
| October 05, 2026 | 211.97 |
| October 02, 2026 | 212.13 |
| October 01, 2026 | 216.18 |
| September 30, 2026 | 218.45 |
| September 29, 2026 | 221.72 |
| September 28, 2026 | 223.08 |
| September 25, 2026 | 221.20 |
| September 24, 2026 | 219.39 |
| September 23, 2026 | 221.85 |
| September 22, 2026 | 223.75 |
| September 21, 2026 | 220.66 |
| September 18, 2026 | 220.00 |
| September 17, 2026 | 221.14 |
| September 16, 2026 | 216.44 |
| September 15, 2026 | 214.42 |
| September 14, 2026 | 213.38 |
| September 11, 2026 | 209.46 |
| September 10, 2026 | 211.05 |
| September 09, 2026 | 212.27 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Regeneron Pharmaceuticals, Inc. | 966.64 |
| AbbVie, Inc. | 507.46 |
| Biogen, Inc. | 250.79 |
| Vertex Pharmaceuticals, Inc. | 534.20 |
| Amgen, Inc. | 685.72 |